artenimol has been researched along with Osteoporosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cheng, Y; Li, P; Liu, H; Lu, X; Ma, Y; Song, C; Wang, Y; Zhang, Z | 1 |
| Cheng, J; Lin, X; Liu, Q; Tickner, J; Wang, T; Xu, J; Yang, M; Yao, J; Yuan, J; Zhao, J; Zhou, L | 1 |
2 other study(ies) available for artenimol and Osteoporosis
| Article | Year |
|---|---|
Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking.
Topics: Artemether; Artemisinins; Artesunate; Caspase 3; Drugs, Chinese Herbal; ErbB Receptors; Humans; Interleukin-17; Mitogen-Activated Protein Kinase 14; Molecular Docking Simulation; Network Pharmacology; Osteoporosis; Prolactin | 2022 |
Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
Topics: Animals; Antimalarials; Artemisinins; Cells, Cultured; Estrogens; Female; Mice; Osteoclasts; Osteoporosis; RANK Ligand; Signal Transduction | 2016 |